We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Women at High Risk of Breast Cancer May Benefit from Alternating Mammography and MRI

By MedImaging International staff writers
Posted on 20 Jan 2009
Magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast tumors not identified by mammography alone, according to recent research.

A research team from the University of Texas M.D. Anderson Cancer Center (Houston, TX, USA) reported their findings in December 2008 at the CRTC-AACR (American Association for Cancer Research) San Antonio (TX, USA) Breast Cancer Symposium.

MRI is known to be more sensitive in detecting breast cancers than mammography, with a 71-100% accuracy compared to 16-40% accuracy for mammography. As a result, annual breast cancer screening for high-risk women now typically includes MRI scanning along with mammography and a clinical breast exam. "In the high-risk population, the recent standard of practice is to perform mammography and MRI every year,” said Huong Le-Petross, M.D., assistant professor of diagnostic radiology at M.D. Anderson and the study's first author. "What we started to do at M.D. Anderson was to see if we could do mammography and then six months later do a breast MRI exam, followed six months later with a mammogram exam, and then six months after that with a breast MRI. That way the women would receive an imaging modality screening every six months.”

In the pilot study, presented at the symposium, the researchers performed a retrospective chart review of 334 women who had participated in a high-risk breast cancer-screening program at M.D. Anderson from January 1997 to December 2007. The women had undergone between one and four MRI screening cycles and were considered to be at high risk if they had hereditary breast and ovarian cancer syndrome, a personal history of breast cancer, a biopsy indicating atypia or lobular carcinoma in situ (LCIS), or a 20% or higher lifetime risk of developing breast cancer, as estimated by the Gail model.

In the all-M.D. Anderson study, 86 of the 334 high-risk women (26%) underwent this alternating approach. Among this group, 46% completed the first round of MRI screening, 28% completed the second round, 13% completed the third round, and 4% completed the fourth round. The other 248 women underwent prophylactic mastectomy or were started on chemoprevention agents. All study participants were given a clinical breast exam every six months. The median follow-up time was two years, with a range of one to four years.

The alternating MRI- and mammography-screening program detected nine cancers among the 86 women: five invasive ductal carcinomas, three invasive lobular carcinoma, and two ductal carcinomas in situ. Five (55%) of these cancers were identified by MRI but not by mammography, three (33%) were found by both MRI and mammography, and one (11%) cancer, a tumor one millimeter in size, was overlooked by both screening techniques. No cancer was detected by mammography alone.

"We found that MRI picked up the majority of cancers, while mammography picked up only three out of the nine,” Dr. Le-Petross noted. With five of the eight cancers detected by MRI, the mammogram from six months earlier was either normal or suggested benign findings. "The global picture is that MRI can pick up cancers that mammography cannot,” Dr. Le-Petross said. "This would suggest that in this population it is more beneficial for the patient to have screening MRI so that we can pick up small lesions before a mammogram can detect them.”

One important unanswered question is whether an alternating MRI- and mammography-screening program will save lives. "That is going to take a five- to 10-year follow-up to determine,” Dr. Le-Petross added. "It is an exciting question because mammography has always been the standard, and now we are challenging that gold standard examination.”

Related Links:

M.D. Anderson Cancer Center




Computed Tomography System
Aquilion ONE / INSIGHT Edition
X-ray Diagnostic System
FDX Visionary-A
New
Ultrasound Needle Guidance System
SonoSite L25
X-Ray Illuminator
X-Ray Viewbox Illuminators

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.